Unified therapeutic-prophylactic nucleobase-lipid nanovaccine with STING pathway agonist (2′3'-cGAMP) to prevent tumor growth recurrence and metastasis
Fields of Study & Subjects
interferon and immune responses
Nanoplatforms for cancer theranostics
Cancer Research and Treatments
Publication details
- Journal / source
- Colloids and Surfaces B Biointerfaces
- Publisher
- Elsevier BV
- Volume
- 262
- Pages
- 115540–115540
- Publication date
- 10 February 2026
- Language
- EN